Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


GEBHART JOHN E Create: Alert

All | News | Filings
Date FiledTypeDescription
07/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/04/2017 4 GEBHART JOHN E (CFO) has filed a Form 4 on KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
Txns: Sold 3,400 shares @ $6.75, valued at $23k
Exercised 7,472 options to buy @ $0
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/27/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
11/02/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Paid exercise price by delivering 3,135 shares @ $9.54, valued at $29.9k
Exercised 7,473 restricted stock units @ $0
10/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/30/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Sold 9,000 shares @ $13.0922, valued at $117.8k
09/12/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Sold 60,000 shares @ $9.857, valued at $591.4k
09/02/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Paid exercise price by delivering 3,135 shares @ $9.84, valued at $30.8k
Exercised 7,473 restricted stock units @ $0
08/02/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Paid exercise price by delivering 3,135 shares @ $12.7, valued at $39.8k
Exercised 7,472 restricted stock units @ $0
05/03/2016 4 GEBHART JOHN E (CFO) has filed a Form 4 on ACUCELA INC.
Txns: Paid exercise price by delivering 33,835 shares @ $35.9, valued at $1.2M
Exercised 89,673 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy